These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 8246375

  • 21. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone.
    Davies UM, Rooney M, Preece MA, Ansell BM, Woo P.
    J Rheumatol; 1994 Jan; 21(1):153-8. PubMed ID: 8151572
    [Abstract] [Full Text] [Related]

  • 22. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients.
    Ingulli E, Singh A, Moazami S, Tejani A.
    Kidney Int Suppl; 1993 Oct; 43():S65-70. PubMed ID: 8246373
    [Abstract] [Full Text] [Related]

  • 23. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE.
    N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875
    [Abstract] [Full Text] [Related]

  • 24. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis.
    Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A.
    Nephrol Dial Transplant; 2010 Mar 09; 25(3):867-73. PubMed ID: 19889872
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep 09; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 27. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 09; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 28. Effect of growth hormone treatment on pubertal growth in a boy with cystinosis and growth failure after renal transplantation.
    Haffner D, Wühl E, Nissel R, Schaefer F, Mehls O.
    Br J Clin Pract Suppl; 1996 Aug 09; 85():7-9. PubMed ID: 8995018
    [Abstract] [Full Text] [Related]

  • 29. [Growth and renal function].
    Antoniazzi F, Mengarda F, Lauriola S, Serra A, Zamboni G, Tatò L.
    Pediatr Med Chir; 1997 Aug 09; 19(5):341-7. PubMed ID: 9493225
    [Abstract] [Full Text] [Related]

  • 30. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
    Cutfield WS, Jackson WE, Jefferies C, Robinson EM, Breier BH, Richards GE, Hofman PL.
    J Pediatr; 2003 Feb 09; 142(2):113-6. PubMed ID: 12584529
    [Abstract] [Full Text] [Related]

  • 31. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA, Postlethwaite RJ, Price DA, Clayton PE.
    Pediatr Nephrol; 2002 Aug 09; 17(8):643-7. PubMed ID: 12185474
    [Abstract] [Full Text] [Related]

  • 32. Improvement of uremic growth failure by recombinant human growth hormone.
    Tönshoff B, Mehls O, Schauer A, Heinrich U, Blum W, Ranke M.
    Kidney Int Suppl; 1989 Nov 09; 27():S201-4. PubMed ID: 2636658
    [Abstract] [Full Text] [Related]

  • 33. Recombinant human growth hormone (rhGH) is effective in pubertal patients.
    Hokken-Koelega AC.
    Br J Clin Pract Suppl; 1996 Aug 09; 85():12-3. PubMed ID: 8995020
    [Abstract] [Full Text] [Related]

  • 34. [Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].
    Sieniawska M, Pańczyk-Tomaszewska M, Ziółkowska H, Jedrzejowski A, Leszczyńska B, Dyras P, Kałuzyńska A, Makulska I, Pietrzyk JA, Rubik J, Siteń G, Stachowski J, Szprynger K, Zurowska A, Roszkowska-Blaim M.
    Pol Merkur Lekarski; 2001 Apr 09; 10(58):263-6. PubMed ID: 11434172
    [Abstract] [Full Text] [Related]

  • 35. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D, Wühl E, Schaefer F, Nissel R, Tönshoff B, Mehls O.
    J Am Soc Nephrol; 1998 Oct 09; 9(10):1899-907. PubMed ID: 9773791
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic value of recombinant human growth hormone in children with chronic renal failure.
    Mehls O, Tönshoff B, Tönshoff C, Haffner D, Blum WF.
    Miner Electrolyte Metab; 1992 Oct 09; 18(2-5):320-4. PubMed ID: 1465083
    [Abstract] [Full Text] [Related]

  • 37. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.
    Wühl E, Haffner D, Gretz N, Offner G, van't Hoff WG, Broyer M, Mehls O.
    Pediatr Res; 1998 Apr 09; 43(4 Pt 1):484-8. PubMed ID: 9545002
    [Abstract] [Full Text] [Related]

  • 38. Factors influencing the response to growth hormone in children with renal disease.
    Rees L, Maxwell H.
    Pediatr Nephrol; 1996 Jun 09; 10(3):337-9. PubMed ID: 8792400
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The effects of recombinant human growth hormone (r-hGH, SM-9500, genotropin) on growth disturbance in children after renal transplantation. Japanese Multi-Center Study (Genotropin) Group on Children with Renal Disease].
    Ito K, Kawaguchi H, Shizume K, Hibi I.
    Nihon Jinzo Gakkai Shi; 1995 Mar 09; 37(3):194-200. PubMed ID: 7731108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.